Turner MedTech Announces MOU for Contract Manufacturing for PollenSense Device

Key Takeaways

  • The Turner MedTech and PollenSense Memorandum of Understanding (MOU) for the manufacturing of the PollenSense device is expected to create new jobs and drive economic growth in Utah, with units going into production for sales in Q2 2025.
  • Turner MedTech is an ISO 13485 certified contract manufacturer. The company provides comprehensive support throughout the product lifecycle, including design support, rapid prototyping, process development, and product assembly & testing.
  • Pollen Sense has revolutionized pollen monitoring with its innovative technology. They have developed automated sensors that provide real-time pollen and mold counts, offering a significant improvement over traditional manual methods. This technology allows for hyperlocal reporting, giving users detailed information about the pollen levels in their specific area.

OREM, Utah - February 27, 2025 - Turner MedTech, a leading medical device contract manufacturer, has signed a Memorandum of Understanding (MOU) with PollenSense to manufacture its innovative pollen detection device.

The PollenSense device uses advanced sensor technology to provide real-time pollen monitoring, helping allergy sufferers manage their symptoms and improve their quality of life.

This partnership brings together a certified medical device manufacturing company with a groundbreaking solution to a common problem for millions of people.

“We are excited to partner with PollenSense to bring this much-needed product to market,” said Charles Jensen, VP/GM of Turner MedTech. “We are confident in our ability to manufacture the PollenSense device to the highest quality standards and are eager to contribute to its success.”

David Brent Noel, CEO of PollenSense, added, “Turner MedTech’s expertise in medical device manufacturing will be invaluable as we scale up production.”

The partnership is expected to create new jobs and drive economic growth in Utah, with units going into production for sales in Q2 2025.


About Turner MedTech

Turner MedTech is a leading contract manufacturer of medical devices headquartered in Orem, Utah. The company specializes in the design, development, and manufacture of complex medical devices, including implants, surgical instruments, and diagnostic equipment. Turner MedTech has a team of experienced engineers and scientists dedicated to developing innovative products that meet the needs of healthcare professionals and patients.

Turner MedTech is an ISO 13485 certified contract manufacturer. The company provides comprehensive support throughout the product lifecycle, including design support, rapid prototyping, process development, and product assembly & testing. Their proven track record accelerates product development and manufacturing for medical, military, dental, and sports solutions. 

About PollenSense

Pollen Sense, headquartered in Provo, Utah, is a company that has revolutionized pollen monitoring with its innovative technology. They have developed automated sensors that provide real-time pollen and mold counts, offering a significant improvement over traditional manual methods. This technology allows for hyperlocal reporting, giving users detailed information about the pollen levels in their specific area.



Key Takeaways

  • The Turner MedTech and PollenSense Memorandum of Understanding (MOU) for the manufacturing of the PollenSense device is expected to create new jobs and drive economic growth in Utah, with units going into production for sales in Q2 2025.
  • Turner MedTech is an ISO 13485 certified contract manufacturer. The company provides comprehensive support throughout the product lifecycle, including design support, rapid prototyping, process development, and product assembly & testing.
  • Pollen Sense has revolutionized pollen monitoring with its innovative technology. They have developed automated sensors that provide real-time pollen and mold counts, offering a significant improvement over traditional manual methods. This technology allows for hyperlocal reporting, giving users detailed information about the pollen levels in their specific area.

Media Gallery

Quotes

We are excited to partner with PollenSense to bring this much-needed product to market. We are confident in our ability to manufacture the PollenSe...
Charles JensenVP/GM of Turner MedTech
Turner MedTech’s expertise in medical device manufacturing will be invaluable as we scale up production.
David Brent NoelCEO of PollenSense

Related Bios

D. Clark Turner Ph.D.
Founder & CEO
Dr. Turner received his B.S. and Ph.D. degrees in analytical chemistry from Brigham Young University in Provo, Utah. He was Founder, CEO, and Chairman of Aribex from 2003 to 2012, and principal inventor of the NOMAD handheld x-ray systems. In recognition of the commercial potential of the NOMAD, Aribex was purchased by Danaher Corporation (a Fortune 500 company with $16B in sales) in November of 2012. Using his proceeds from the sale of Aribex, Dr. Turner has founded Turner Ventures, an independent, privately held physical and life sciences investment firm that funds promising seed- and early-stage companies. In addition to angel investments, Turner Ventures’ operating portfolio includes Turner Innovations, an early stage research and development company focused on bridging the gaps between fundamental research and commercialization of technologies based on that research.
View Full Bio>>
Charles Jensen
VP and General Manager
Charles received his BS degree in Manufacturing Engineering, and has since supported companies such as The Boeing Company, Moxtek, Inc., and others in advancing a host of new products into production. Charles’ work at Boeing included New Airplane Product Development, with a focus on Design for Manufacturing. At Moxtek, Charles was instrumental in the production launch of their Bullet and Magnum miniature x-ray tubes and power supplies, ultimately leading the company’s entire Research & Development team. His current role of GM builds on this R&D leadership experience and his success in launching new products into production.
View Full Bio>>
Tim Weeks
CPA : CFO
Tim earned an accounting degree from Brigham Young University and began his career with Ernst and Young in Denver. He is a licensed CPA in the state of Colorado. Tim has owned and served as President and CEO of three organizations and as the CFO and executive in several others. He is currently a partner and outsourced CFO with Company Vitals and serves as the CFO of multiple client companies.
View Full Bio>>
Matt Stewart
Supply Chain Manager
Matt Stewart has over 20 years of Supply Chain Management experience from Fortune 500 companies in diverse industries such as Oil & Gas to Aerospace to Hospitality. He has created supply chain systems from scratch at several of these companies, including inventory management optimization using Kanban and other lean methodologies, single-piece flow of receiving and shipping functions, and supply base performance excellence through partnerships and spend category performance improvements. His experience includes both import and export functional expertise. He also has extensive experience with Oracle and other ERP systems, including fulfilling the role of NetSuite Administrator at Turner MedTech.
View Full Bio>>

Contacts

Chelli Miller
chelli@contentcarnivores.com
219-921-6823
Media